Jiwon Kim1, Javid Alakbarli2, Brian Yum2, Nathan H Tehrani2, Meridith P Pollie2, Christiane Abouzeid2, Antonino Di Franco2, Mark B Ratcliffe3,4, Athena Poppas5, Robert A Levine6, Richard B Devereux2, Jonathan W Weinsaft2. 1. Greenberg Cardiology Division, Department of Medicine, Weill Cornell Medical College, 525 East 68th Street, New York, NY, 10021, USA. jik9027@med.cornell.edu. 2. Greenberg Cardiology Division, Department of Medicine, Weill Cornell Medical College, 525 East 68th Street, New York, NY, 10021, USA. 3. Division of Cardiology, Department of Surgery, University of California, San Francisco, Veterans Affairs Medical Center, San Francisco, CA, USA. 4. Department of Bioengineering, University of California, San Francisco, Veterans Affairs Medical Center, San Francisco, CA, USA. 5. Lifespan Cardiovascular Institute, The Warren Alpert Medical School of Brown University, Providence, RI, USA. 6. Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Abstract
Ischemic mitral regurgitation (iMR) augments risk for right ventricular dysfunction (RVDYS). Right and left ventricular (LV) function are linked via common coronary perfusion, but data is lacking regarding impact of LV ischemia and infarct transmurality-as well as altered preload and afterload-on RV performance. In this prospective multimodality imaging study, stress CMR and 3-dimensional echo (3D-echo) were performed concomitantly in patients with iMR. CMR provided a reference for RVDYS (RVEF < 50%), as well as LV function/remodeling, ischemia and infarction. Echo was used to test multiple RV performance indices, including linear (TAPSE, S'), strain (GLS), and volumetric (3D-echo) approaches. 90 iMR patients were studied; 32% had RVDYS. RVDYS patients had greater iMR, lower LVEF, larger global ischemic burden and inferior infarct size (all p < 0.05). Regarding injury pattern, RVDYS was associated with LV inferior ischemia and infarction (both p < 0.05); 80% of affected patients had substantial viable myocardium (< 50% infarct thickness) in ischemic inferior segments. Regarding RV function, CMR RVEF similarly correlated with 3D-echo and GLS (r = 0.81-0.87): GLS yielded high overall performance for CMR-evidenced RVDYS (AUC: 0.94), nearly equivalent to that of 3D-echo (AUC: 0.95). In multivariable regression, GLS was independently associated with RV volumetric dilation on CMR (OR - 0.90 [CI - 1.19 to - 0.61], p < 0.001) and 3D echo (OR - 0.43 [CI - 0.84 to - 0.02], p = 0.04). Among patients with iMR, RVDYS is associated with potentially reversible processes, including LV inferior ischemic but predominantly viable myocardium and strongly impacted by volumetric loading conditions.
Ischemic mitral regurgitation (iMR) augments risk for pan class="Disease">right ventricular dysfunction (RVDYS). Right and left ventricular (LV) function are linked via common coronary perfusion, but data is lacking regarding impact of LV ischemia and infarct transmurality-as well as altered preload and afterload-on RV performance. In this prospective multimodality imaging study, stress CMR and 3-dimensional echo (3D-echo) were performed concomitantly in patients with iMR. CMR provided a reference for RVDYS (RVEF < 50%), as well as LV function/remodeling, ischemia and infarction. Echo was used to test multiple RV performance indices, including linear (TAPSE, S'), strain (GLS), and volumetric (3D-echo) approaches. 90 iMR patients were studied; 32% had RVDYS. RVDYS patients had greater iMR, lower LVEF, larger global ischemic burden and inferior infarct size (all p < 0.05). Regarding injury pattern, RVDYS was associated with LV inferior ischemia and infarction (both p < 0.05); 80% of affected patients had substantial viable myocardium (< 50% infarct thickness) in ischemic inferior segments. Regarding RV function, CMR RVEF similarly correlated with 3D-echo and GLS (r = 0.81-0.87): GLS yielded high overall performance for CMR-evidenced RVDYS (AUC: 0.94), nearly equivalent to that of 3D-echo (AUC: 0.95). In multivariable regression, GLS was independently associated with RV volumetric dilation on CMR (OR - 0.90 [CI - 1.19 to - 0.61], p < 0.001) and 3D echo (OR - 0.43 [CI - 0.84 to - 0.02], p = 0.04). Among patients with iMR, RVDYS is associated with potentially reversible processes, including LV inferior ischemic but predominantly viable myocardium and strongly impacted by volumetric loading conditions.
Entities:
Keywords:
Echocardiography; Magnetic resonance imaging (MRI); Remodeling; Right ventricle; Valvular heart disease
Authors: Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani Journal: Circulation Date: 2002-01-29 Impact factor: 29.690
Authors: Igor Klem; John F Heitner; Dipan J Shah; Michael H Sketch; Victor Behar; Jonathan Weinsaft; Peter Cawley; Michele Parker; Michael Elliott; Robert M Judd; Raymond J Kim Journal: J Am Coll Cardiol Date: 2006-03-27 Impact factor: 24.094
Authors: Lawrence G Rudski; Wyman W Lai; Jonathan Afilalo; Lanqi Hua; Mark D Handschumacher; Krishnaswamy Chandrasekaran; Scott D Solomon; Eric K Louie; Nelson B Schiller Journal: J Am Soc Echocardiogr Date: 2010-07 Impact factor: 5.251
Authors: Richard B Devereux; Mary J Roman; Vittorio Palmieri; Jennifer E Liu; Elisa T Lee; Lyle G Best; Richard R Fabsitz; Richard J Rodeheffer; Barbara V Howard Journal: Am Heart J Date: 2003-09 Impact factor: 4.749
Authors: Heleen B van der Zwaan; Marcel L Geleijnse; Jackie S McGhie; Eric Boersma; Willem A Helbing; Folkert J Meijboom; Jolien W Roos-Hesselink Journal: Eur J Echocardiogr Date: 2011-08-02
Authors: Leonardo A M Zornoff; Hicham Skali; Marc A Pfeffer; Martin St John Sutton; Jean L Rouleau; Gervasio A Lamas; Ted Plappert; Jacques R Rouleau; Lemuel A Moyé; Sandra J Lewis; Eugene Braunwald; Scott D Solomon Journal: J Am Coll Cardiol Date: 2002-05-01 Impact factor: 24.094
Authors: Eric Larose; Peter Ganz; H Glenn Reynolds; Sharmila Dorbala; Marcelo F Di Carli; Kenneth A Brown; Raymond Y Kwong Journal: J Am Coll Cardiol Date: 2007-02-09 Impact factor: 24.094
Authors: John P Greenwood; Neil Maredia; John F Younger; Julia M Brown; Jane Nixon; Colin C Everett; Petra Bijsterveld; John P Ridgway; Aleksandra Radjenovic; Catherine J Dickinson; Stephen G Ball; Sven Plein Journal: Lancet Date: 2011-12-22 Impact factor: 79.321
Authors: Johan H C Reiber; Gabriel T R Pereira; Luis A P Dallan; Hiram G Bezerra; Johan De Sutter; Arthur E Stillman; Nico R L Van de Veire; Joachim Lotz Journal: Int J Cardiovasc Imaging Date: 2020-05 Impact factor: 2.357
Authors: Jiwon Kim; Brian Yum; Maria C Palumbo; Razia Sultana; Nathaniel Wright; Mukund Das; Cindy You; Chaya S Moskowitz; Robert A Levine; Richard B Devereux; Jonathan W Weinsaft Journal: JACC Cardiovasc Imaging Date: 2020-08-19
Authors: Jiwon Kim; Spencer Krichevsky; Lola Xie; Maria Chiara Palumbo; Sara Rodriguez-Diego; Brian Yum; Lillian Brouwer; Richard T Silver; Andrew I Schafer; Ellen K Ritchie; Maria Mia Yabut; Claudia Sosner; Evelyn M Horn; Richard B Devereux; Joseph M Scandura; Jonathan W Weinsaft Journal: J Am Soc Echocardiogr Date: 2019-10-03 Impact factor: 5.251
Authors: Lisa Q Rong; Brian Yum; Christiane Abouzeid; Maria Chiara Palumbo; Lillian R Brouwer; Richard B Devereux; Leonard N Girardi; Jonathan W Weinsaft; Mario Gaudino; Jiwon Kim Journal: Cardiovasc Ultrasound Date: 2019-06-07 Impact factor: 2.062
Authors: Yue Zhang; Vicky Y Wang; Ashley E Morgan; Jiwon Kim; Liang Ge; Julius M Guccione; Jonathan W Weinsaft; Mark B Ratcliffe Journal: Front Physiol Date: 2020-03-13 Impact factor: 4.566